Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409851 · ClinicalTrials.gov registry record · Phase 3
One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,293
- Enrollment target
NCT00409851 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 1,293 participants.
The verdict
NCT00409851, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,293 participants
- Enrollment target
Study Summary
A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.
Interventions
- DRUG valsartan+amlodipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,293 participants |
| Start Date | 2003-04 |
| Est. Completion | 2005-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00409851
The ClinicalTrials.gov registry entry for NCT00409851 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,293 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valsartan+amlodipine is the first listed.
NCT00409851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00409851 about?
NCT00409851 is a clinical study titled "One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension". A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.
What is the current status of trial NCT00409851?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,293 participants. The study started on 2003-04. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00409851?
The interventions under investigation include: valsartan+amlodipine (DRUG).
Who is sponsoring clinical trial NCT00409851?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.